Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Niemietz

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Molecules (Basel, Switzerland)|October 6, 2015
Therapeutic Oligonucleotides Targeting Liver Disease: TTR AmyloidosisChristoph Niemietz, Gursimran Chandhok, Hartmut Schmidt
Biochemistry and Biophysics Reports|July 22, 2022
Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiationMatthias Weiand, Paula Ballmaier, Christoph Niemietz, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2019
APOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNAChristoph Niemietz, Oksana Nadzemova, Andree Zibert, et al.
Journal of Cell Science|October 19, 2018
Hepatocyte-like cells reveal novel role of SERPINA1 in transthyretin amyloidosisChristoph Niemietz, Lutz Fleischhauer, Vanessa Sandfort, et al.
Deutsche Medizinische Wochenschrift (1946)|March 16, 2018
[Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder]Christoph Niemietz, Christoph Röcken, Matthias Schilling, et al.
Metallomics : Integrated Biometal Science|August 15, 2017
Downregulation of hepatic multi-drug resistance protein 1 (MDR1) after copper exposureSara Reinartz Groba, Sarah Guttmann, Christoph Niemietz, et al.
Oncotarget|February 9, 2018
Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cellsSarah Guttmann, Gursimran Chandhok, Sara Reinartz Groba, et al.
International Journal of Molecular Sciences|September 10, 2021
In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin ProteolysisFilipa Bezerra, Christoph Niemietz, Hartmut H J Schmidt, et al.
Experimental Cell Research|August 10, 2020
SERPINA1 modulates expression of amyloidogenic transthyretinChristoph Niemietz, Filipa Bezerra, Maria Rosário Almeida, et al.
Journal of Medical Genetics|April 24, 2019
Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapyMalte Lenders, Franciska Stappers, Christoph Niemietz, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecules (Basel, Switzerland)|October 6, 2015
Therapeutic Oligonucleotides Targeting Liver Disease: TTR AmyloidosisChristoph Niemietz, Gursimran Chandhok, Hartmut Schmidt
Biochemistry and Biophysics Reports|July 22, 2022
Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiationMatthias Weiand, Paula Ballmaier, Christoph Niemietz, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2019
APOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNAChristoph Niemietz, Oksana Nadzemova, Andree Zibert, et al.
Journal of Cell Science|October 19, 2018
Hepatocyte-like cells reveal novel role of SERPINA1 in transthyretin amyloidosisChristoph Niemietz, Lutz Fleischhauer, Vanessa Sandfort, et al.
Deutsche Medizinische Wochenschrift (1946)|March 16, 2018
[Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder]Christoph Niemietz, Christoph Röcken, Matthias Schilling, et al.
Metallomics : Integrated Biometal Science|August 15, 2017
Downregulation of hepatic multi-drug resistance protein 1 (MDR1) after copper exposureSara Reinartz Groba, Sarah Guttmann, Christoph Niemietz, et al.
Oncotarget|February 9, 2018
Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cellsSarah Guttmann, Gursimran Chandhok, Sara Reinartz Groba, et al.
International Journal of Molecular Sciences|September 10, 2021
In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin ProteolysisFilipa Bezerra, Christoph Niemietz, Hartmut H J Schmidt, et al.
Experimental Cell Research|August 10, 2020
SERPINA1 modulates expression of amyloidogenic transthyretinChristoph Niemietz, Filipa Bezerra, Maria Rosário Almeida, et al.
Journal of Medical Genetics|April 24, 2019
Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapyMalte Lenders, Franciska Stappers, Christoph Niemietz, et al.
Pageof 2